analyst
VK
NASDAQ · VKTX
Viking Therapeutics, Inc.
Healthcare · Biotechnology
$29.95
Down-$1.58 (-5.01%)
Updated Sep 16, 2026, 12:12 PM
SID Score
4.6/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.21B
- P/E ratio
- -17.61
- Dividend yield
- 0.00%
- 52-week range
- $27.16 – $42.79
- Volume
- 2.81M
- Avg. volume
- 4.44M
Price performance
VKTX price history
1M range · 20 trading sessions · Daily adjusted prices
VKTX closed at $29.95 after 20 trading sessions, down 10.25% for the selected period.
- Last close
- $29.95
- Period change
- -10.25%
- Period low
- $29.95
- Period high
- $35.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $31.21 | $31.25 | $29.70 | $29.95 | 2.81M |
| Sep 14, 2026 | $31.70 | $32.43 | $31.39 | $31.53 | 1.85M |
| Sep 11, 2026 | $32.26 | $33.05 | $31.70 | $31.98 | 2.21M |
| Sep 10, 2026 | $32.50 | $32.65 | $31.87 | $32.13 | 1.72M |
| Sep 9, 2026 | $33.36 | $34.60 | $32.59 | $32.70 | 2.04M |
| Sep 8, 2026 | $34.63 | $34.81 | $33.53 | $33.68 | 1.87M |
| Sep 4, 2026 | $33.75 | $34.95 | $33.56 | $34.87 | 1.4M |
| Sep 3, 2026 | $34.00 | $34.45 | $33.68 | $33.98 | 1.39M |
| Sep 2, 2026 | $33.67 | $34.75 | $32.7708 | $33.50 | 1.57M |
| Sep 1, 2026 | $32.61 | $33.71 | $32.38 | $33.67 | 1.68M |
| Aug 31, 2026 | $31.77 | $32.98 | $31.70 | $32.78 | 1.78M |
| Aug 28, 2026 | $33.75 | $33.86 | $31.98 | $32.16 | 2.38M |
| Aug 27, 2026 | $34.33 | $34.39 | $33.15 | $33.86 | 2.21M |
| Aug 26, 2026 | $34.09 | $34.75 | $33.802 | $34.38 | 1.14M |
| Aug 25, 2026 | $33.67 | $34.994 | $33.43 | $34.17 | 2.1M |
| Aug 24, 2026 | $33.75 | $33.765 | $32.61 | $33.23 | 1.75M |
| Aug 21, 2026 | $34.79 | $34.98 | $33.47 | $33.89 | 1.5M |
| Aug 20, 2026 | $35.79 | $35.79 | $33.9618 | $34.36 | 1.67M |
| Aug 19, 2026 | $34.10 | $36.26 | $33.8301 | $35.98 | 2.69M |
| Aug 18, 2026 | $33.42 | $33.94 | $33.00 | $33.37 | 1.19M |
Latest VKTX news
The latest Smart Investors Daily articles mentioning VKTX.
Stock researchResearch & News · Analysis
Loading stock research…